Efficacy and safety of ultra‐rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO‐Peds trial

AIMS: To evaluate the efficacy and safety of ultra‐rapid lispro (URLi) versus lispro in a paediatric population with type 1 diabetes (T1D) in a Phase 3, treat‐to‐target study. MATERIALS AND METHODS: After a 4‐week lead‐in to optimize basal insulin, participants were randomized to double‐blind URLi (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadwa, R. Paul, Laffel, Lori M., Franco, Denise R., Dellva, Mary Anne, Knights, Alastair W., Pollom, Robyn K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087819/
https://www.ncbi.nlm.nih.gov/pubmed/36054737
http://dx.doi.org/10.1111/dom.14849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087819/
https://www.ncbi.nlm.nih.gov/pubmed/36054737
http://dx.doi.org/10.1111/dom.14849

Ejemplares similares